Completed NA INTERVENTIONAL 2-arm NCT00507221

Empiric Therapy of Helminth Co-infection to Reduce HIV-1 Disease Progression (THE or PHE)

Sponsor: Centers for Disease Control and Prevention

Interventions Albendazole Current standard of care in Kenya Praziquantel

Updated 6 times since 2017 Last updated: Nov 18, 2014 Started: Feb 29, 2008 Primary completion: Jul 31, 2011 Completion: Oct 31, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00507221, this NA trial focuses on HIV Infections and Helminthiasis and remains completed. Sponsored by Centers for Disease Control and Prevention, it has been updated 6 times since 2008, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Feb 2017 — Jun 2018 [monthly]

Completed NA

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed NA

First recorded

Feb 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Centers for Disease Control and Prevention
Kenya Medical Research Institute
University of Washington

Data source: University of Washington

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Nairobi, Kenya